Van Berkom & Associates Inc. / CHE
Van Berkom & Associates Inc.’s Chemed Corp New Position
Does Van Berkom & Associates Inc. own Chemed Corp New (CHE)? Yes — 330.2K shares worth $125M (+2.04% of its 13F portfolio) as of Q1 2026, up from 174.9K shares the prior filed quarter.
Position Value
$125M
Q1 2026
Shares
330.2K
% of Portfolio
+2.04%
Quarters Held
30
currently held
Position History CHE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 330.2K | $125M | +2.04% |
| Q4 2025 | 174.9K | $75M | +2.16% |
| Q3 2025 | 170.8K | $76M | +2.21% |
| Q2 2025 | 128.4K | $63M | +1.86% |
| Q1 2025 | 108.0K | $66M | +2.13% |
| Q4 2024 | 128.5K | $68M | +2.02% |
| Q3 2024 | 135.7K | $82M | +2.24% |
| Q2 2024 | 130.0K | $71M | +2.11% |
| Q1 2024 | 115.8K | $74M | +2.12% |
| Q4 2023 | 118.5K | $69M | +2.02% |
| Q3 2023 | 130.0K | $68M | +2.20% |
| Q2 2023 | 109.9K | $60M | +2.16% |
| Q1 2023 | 111.3K | $60M | +2.21% |
| Q4 2022 | 104.8K | $53M | +2.29% |
| Q3 2022 | 106.8K | $47M | +2.22% |
| Q2 2022 | 108.1K | $51M | +2.12% |
| Q1 2022 | 110.4K | $56M | +2.01% |
| Q4 2021 | 122.1K | $65M | +1.91% |
| Q3 2021 | 124.4K | $58M | +1.75% |
| Q2 2021 | 135.1K | $64M | +1.76% |
| Q1 2021 | 173.9K | $80M | +1.75% |
| Q4 2020 | 184.3K | $98M | +2.25% |
| Q3 2020 | 185.0K | $89M | +2.58% |
| Q2 2020 | 186.1K | $84M | +2.46% |
| Q1 2020 | 200.0K | $87M | +3.10% |
| Q4 2019 | 209.4K | $92M | +2.49% |
| Q3 2019 | 209.1K | $87M | +2.14% |
| Q2 2019 | 251.9K | $91M | +2.63% |
| Q1 2019 | 253.1K | $81M | +2.57% |
| Q4 2018 | 256.7K | $73M | +2.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Van Berkom & Associates Inc.’s full portfolio or all institutional holders of CHE.